Cadila Healthcare reports over 6-fold jump in Q2 consolidated net profit

29 Oct 2021 Evaluate

Cadila Healthcare has reported results for second quarter ended September 30, 2021.

The company has reported 97.02% fall in its net profit at Rs 14.1 crore for the quarter under review as compared to Rs 473 crore for the same quarter in the previous year. Total income of the company decreased by 12.49% at Rs 2078.30 crore for Q2FY22 as compared Rs 2117.70 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported over 6-fold jump in its net profit at Rs 3002.30 crore for the quarter under review as compared to Rs 473.40 crore for the same quarter in the previous year. Total income of the company increased by 4.12% at Rs 3838.10 crore for Q2FY22 as compared Rs 3686.40 crore for the corresponding quarter previous year.

Zydus Lifesciences Share Price

896.60 3.15 (0.35%)
28-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.15
Dr. Reddys Lab 1224.30
Cipla 1328.25
Zydus Lifesciences 896.60
Lupin 2121.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×